Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8986710 None

Patent 8986710 was granted and assigned to Pfizer Limited on March, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Susan Kay Hoiseth0

Annaliesa Sybil Anderson0

Justin Keith Moran0

Kathrin Ute Jansen0

Mark E. Ruppen0

Date of Patent

March 24, 2015

0

Patent Application Number

137875940

Date Filed

March 6, 2013

0

Patent Citations Received

US Patent 12077795 Method for biocatalytic protein-oligonucleotide conjugation

0

US Patent 11707514 Neisseria meningitidis vaccine

0

Patent Primary Examiner

0

Patent abstract

In one aspect, the invention relates to an isolated polypeptide comprising an amino acid sequence that is at least 95% identical to SEQ ID NO: 71. In another aspect, the invention relates to an immunogenic composition including an isolated non-lipidated, non-pyruvylated ORF2086 polypeptide from Neisseria meningitidis serogroup B, and at least one conjugated capsular saccharide from a meningococcal serogroup.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8986710 None

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool